Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02951637
What this trial is testing

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Who this might be right for
Lung Adenocarcinoma
Shanghai Chest Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02558894
What this trial is testing

Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
AstraZeneca 65
Testing effectiveness (Phase 2)Looking for participantsNCT05558904
What this trial is testing

An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

Who this might be right for
Lung Adenocarcinoma
Jonsson Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Ended earlyNCT01511081
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)

Who this might be right for
Non-small-cell Lung Cancer
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Who this might be right for
Advanced CancerAnal CarcinomaAnal Cancer+22 more
Merck Sharp & Dohme LLC 1,609
Early research (Phase 1)Ended earlyNCT01441128
What this trial is testing

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungAdenocarcinomaCarcinoma, Squamous Cell+1 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Active Not RecruitingNCT06447662
What this trial is testing

Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 64
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Not applicableStudy completedNCT01603849
What this trial is testing

Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis

Who this might be right for
Lung Cancer
Instituto Nacional de Cancerologia de Mexico 84
Early research (Phase 1)Not Yet RecruitingNCT07583316
What this trial is testing

First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Esophagus CancerHead and Neck Cancer+1 more
Corregene Biotechnology Co., Ltd 192
Testing effectiveness (Phase 2)Study completedNCT00411047
What this trial is testing

Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)UnknownNCT06519110
What this trial is testing

Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations

Who this might be right for
Advanced Solid Tumor
Convalife (Shanghai) Co., Ltd. 60
Early research (Phase 1)Study completedNCT00004879
What this trial is testing

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

Who this might be right for
Colorectal CancerEsophageal CancerKidney Cancer+3 more
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06899789
What this trial is testing

Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

Who this might be right for
Immune Checkpoint Inhibitors-induced ColitisAdvanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney AdenocarcinomaIleo-colitis+1 more
Fondazione IRCCS Policlinico San Matteo di Pavia 250
Early research (Phase 1)Ended earlyNCT02650635
What this trial is testing

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more
Mayo Clinic 4
Not applicableEnded earlyNCT02121925
What this trial is testing

Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up

Who this might be right for
Lung CancerNSCLCLung Adenocarcinoma
Myriad Genetic Laboratories, Inc. 227
Early research (Phase 1)Looking for participantsNCT04147078
What this trial is testing

Personalized DC Vaccine for Postoperative Cancer

Who this might be right for
Gastric CancerHepatocellular CarcinomaNon-Small-Cell Lung Cancer+1 more
Sichuan University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06281678
What this trial is testing

IBI363 in Subjects with Advanced Solid Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer+1 more
Innovent Biologics (Suzhou) Co. Ltd. 178
Large-scale testing (Phase 3)Study completedNCT00003685
What this trial is testing

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Who this might be right for
FatigueLung CancerNausea and Vomiting+3 more
NCIC Clinical Trials Group 230
Next Page